2024 HCPCS Code J7626
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
TAGS: inhalation administered final through
| Short Description | Budesonide non-comp unit |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Code Added Date | January 01, 2002 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J7699 - Inhalation solution for dme
- J7799 - Non-inhalation drug for dme
- J7999 - Compounded drug, noc
- J8498 - Antiemetic rectal/supp nos
- J8499 - Oral prescrip drug non chemo
- J8501 - Oral aprepitant
- J8510 - Oral busulfan
- J8515 - Cabergoline, oral 0.25mg
- J8520 - Capecitabine, oral, 150 mg
- J8521 - Capecitabine, oral, 500 mg
- J8530 - Cyclophosphamide oral 25 mg
- J8540 - Oral dexamethasone
- J8560 - Etoposide oral 50 mg
- J8562 - Oral fludarabine phosphate
- J8565 - Gefitinib oral
- J8597 - Antiemetic drug oral nos
- J8600 - Melphalan oral 2 mg
- J8610 - Methotrexate oral 2.5 mg
- J8611 - Oral methotrexate (jylamvo)
- J8612 - Oral methotrexate (xatmep)